Why Women from Africa and the Gulf Are Choosing India for Breast Cancer Treatment
The same drugs. The same surgical protocols. The same oncologists trained at MD Anderson and the Royal Marsden. At 80–90% less cost than the US or UK — with no waiting list and a medical visa in five to ten days. This is why patients from Nigeria, Kenya, Ghana, the UAE, and Bangladesh are choosing India for breast cancer treatment.
By Gaf Healthcare Editorial Team
2026-05-09
Why Women from Africa and the Gulf Are Choosing India for Breast Cancer Treatment
The same surgery. The same drugs. The same protocols used in London and New York. At 80 to 90 percent less cost — with no waiting list, no rationing, and no compromise on the standard of care. This is not a new trend. It is a decision hundreds of thousands of patients have already made.
Patients from Nigeria, Ghana, Kenya, Tanzania, the UAE, Saudi Arabia, Oman, and Bangladesh are among the largest groups seeking breast cancer treatment in India. The combination of internationally trained oncology teams, current-generation drugs, and costs that are 80–90% lower than the US or UK makes India the most viable option for the majority of international patients who cannot access — or afford — care at home.
- Why treatment at home is not always an option
- Why the US and UK are not realistic for most patients
- Seven reasons India has become the answer
- What breast cancer treatment actually costs in India
- Which countries are sending the most patients — and why
- The four hospitals GAF Healthcare recommends most
- How the process works — from your country to discharge
Why treatment at home is not always an option
This is the part that most medical tourism guides skip over. They jump straight to hospital rankings and cost tables. But the real reason patients from Nigeria, Ghana, Kenya, Tanzania, and the Gulf travel to India for breast cancer treatment is not primarily about cost.
It is about availability.
Robotic surgery for breast cancer is not available in most of sub-Saharan Africa. Trastuzumab — the standard drug for HER2-positive breast cancer — is not reliably stocked in most African public hospitals. Pembrolizumab for triple-negative breast cancer is not on formulary in most Gulf countries outside of specialist centres. Genomic tests like Oncotype DX, which determine whether chemotherapy is necessary at all, are not performed locally in most of the countries GAF Healthcare's patients come from.
The conversation is not "India vs my local hospital." For most of these patients, it is "India vs no treatment."
The World Health Organisation estimates that more than 90% of people in low- and middle-income countries lack access to basic cancer treatment. In sub-Saharan Africa, fewer than 30 radiation therapy machines serve a population of over one billion people. A woman diagnosed with stage II breast cancer in Zambia, Uganda, or Senegal is not choosing between good options. She is choosing between travelling for care and receiving no meaningful treatment at all. India closes that gap — at a price that is within reach.
Diagnosed with breast cancer and unsure what is available near you?
Share your diagnosis with our team. We will tell you honestly whether what you need is available locally, or whether India is the right next step — at no charge, within 24 hours.
Get a Free Assessment →Why the US and UK are not realistic for most patients
The obvious alternative to local care is Western care. And for patients who can afford it, the US and UK offer excellent oncology. But the numbers make them inaccessible for the overwhelming majority of international patients.
A full course of breast cancer treatment in the United States — surgery, chemotherapy, twelve months of trastuzumab for HER2-positive disease, and radiation — costs between $180,000 and $400,000. Without US health insurance, that figure is paid out of pocket.
The UK's NHS does not treat non-residents. Private treatment in the UK costs £60,000–£130,000 for a full breast cancer course. Germany and France are comparable.
Beyond cost, there is the visa reality. Medical visas for the US and UK are slow, uncertain, and frequently denied for patients from African countries. India issues medical visas for most nationalities within five to ten working days — including for two accompanying family members.
India is not a consolation prize. It is the only realistic option that combines world-class oncology with prices that are within reach — and a medical visa system that actually works for African and Gulf patients.
Seven reasons India has become the answer
The same drugs, the same protocols — not a diluted version
India's top cancer centres follow NCCN and ESMO oncology guidelines — the same frameworks used at MD Anderson and the Royal Marsden. Trastuzumab, pertuzumab, pembrolizumab, palbociclib, olaparib, T-DXd — all are available. The formulary is current. The protocol is not simplified for cost. The drug is simply cheaper to manufacture in India.
Biosimilar biologics at a fraction of Western prices
Trastuzumab — brand name Herceptin — costs $6,000–$8,000 per cycle in the US. In India, biosimilar trastuzumab approved by India's drug regulator costs $300–$500 per cycle. It is clinically identical. Over twelve months of treatment, the saving runs to $60,000–$90,000 on this drug alone. This is not a different drug. It is the same molecule, manufactured under different economics.
Surgeons trained at the world's best institutions
The surgical oncologists and reconstructive surgeons at Apollo, Fortis, Medanta, and Tata Memorial trained at MD Anderson, Memorial Sloan Kettering, the Royal Marsden, and leading European cancer centres. They returned to India. The skill is the same. The salary structure — and therefore the procedure cost — is not.
Multidisciplinary tumour boards as standard, not premium
At every major Indian cancer centre GAF Healthcare works with, your case is reviewed collectively before treatment begins — surgical oncologist, medical oncologist, radiation oncologist, pathologist, and radiologist together. This is not a premium add-on. It is how every patient's care is planned. In many countries, access to a tumour board review requires referral to a specialist centre that may not exist locally.
No waiting lists
In countries with public healthcare systems, breast cancer patients routinely wait six to twelve weeks for a surgical date. In India's private cancer centres, international patients are typically scheduled within one to two weeks of arrival. For breast cancer, speed matters clinically. A stage II tumour that waits three months does not stay stage II.
Infrastructure built for international patients
Apollo, Fortis, Medanta, and Tata Memorial have dedicated international patient departments with coordinators who speak Arabic, French, Swahili, Bengali, and English. Visa invitation letters, airport transfers, accommodation near the hospital, dietary accommodation, and prayer facilities are standard. These centres have been treating international patients for decades. The experience shows.
Seamless handoff when you go home
India's oncology teams produce complete, internationally formatted discharge summaries, surgical records, pathology reports, and ongoing treatment plans in English. GAF Healthcare coordinates the transfer of this documentation to your local oncologist so that care continues without interruption after you return home. You do not need to choose between treatment in India and continuity at home. You get both.
Ready to find out if India is right for your diagnosis?
Share your biopsy report and staging details. Our medical team will review your case, recommend the right hospital, and give you an itemised cost estimate — at no charge, within 24 hours.
Get My Free Treatment Plan →What breast cancer treatment actually costs in India
Cost transparency is something most hospitals — in any country — are reluctant to provide upfront. GAF Healthcare's position is the opposite. Patients making decisions about international travel for cancer treatment need real numbers, not ranges so wide they are meaningless.
The figures below are based on GAF Healthcare's hospital network pricing as of 2025–2026. They represent all-in costs — surgery, hospital stay, anaesthesia, pathology, and drugs — not the procedure fee alone.
| Treatment | USA | UK | India |
|---|---|---|---|
| Lumpectomy + sentinel node biopsy | $25,000–$50,000 | £12,000–£22,000 | $2,500–$5,000 |
| Mastectomy + implant reconstruction | $50,000–$85,000 | £20,000–£40,000 | $6,500–$12,000 |
| Mastectomy + DIEP flap reconstruction | $80,000–$150,000 | £35,000–£65,000 | $10,000–$18,000 |
| Full HER2+ treatment course (surgery + 12 mo trastuzumab + chemo) | $180,000–$350,000 | £60,000–£110,000 | $12,000–$22,000 |
| Trastuzumab biosimilar (per cycle) | $6,000–$8,000 | £3,000–£5,000 | $300–$500 |
| Full TNBC treatment (neoadjuvant + surgery + pembrolizumab) | $200,000–$400,000 | £70,000–£130,000 | $14,000–$28,000 |
| Full staging workup (MRI, CT, PET-CT) | $8,000–$14,000 | £4,000–£7,000 | $600–$1,200 |
GAF Healthcare hospital network data, 2025–2026. US figures from FAIR Health. UK figures from NHS reference costs and private sector benchmarks.
GAF Healthcare cost estimates cover surgery, anaesthesia, hospital stay, nursing, pathology, post-operative medications, and pre-discharge follow-up. They do not include flights or accommodation — but we provide guidance on both. There are no hidden line items. If additional procedures are recommended after surgery, they are quoted separately before proceeding. Transparency is not a marketing claim for us. It is the foundation of the patient relationship.
Want an exact cost figure for your specific diagnosis and treatment plan?
Share your biopsy report, staging scans, and diagnosis details. We will send itemised quotes from 2–3 shortlisted Indian hospitals within 24 hours — at no charge.
Request My Cost Estimate →Which countries are sending the most patients — and why
GAF Healthcare works with patients from over 40 countries. These are the regions and nationalities we see most consistently — and the specific reasons each group finds India particularly compelling.
- Limited access to targeted therapy locally
- No reliable trastuzumab supply in public hospitals
- High prevalence of triple-negative breast cancer
- India visa granted in 5–7 days
- Surgery available but reconstruction capability limited
- Pembrolizumab not on public formulary
- Long waits at Kenyatta National Hospital
- Direct flights to Delhi and Mumbai
- Radiation therapy capacity severely limited
- TNBC rates significantly above global average
- Oncotype DX genomic testing unavailable locally
- Strong Ghanaian diaspora already using India
- Surgery available but costs rival the US
- Some drugs on restricted access only
- Expatriate population without insurance coverage
- 3-hour flight to Mumbai or Delhi
- Non-Saudi residents without CCHI coverage
- Private hospital costs comparable to Europe
- Patients preferring female surgeon teams
- India offers dedicated female oncology teams
- Limited specialist oncology outside Dhaka
- Targeted therapy largely unavailable publicly
- India costs affordable on Bangladeshi income
- Cultural and linguistic familiarity with India
- Radiotherapy capacity severely limited nationally
- Targeted therapy largely unavailable in public hospitals
- India medical visa issued in 5–7 days
- Strong referral network via GAF Healthcare
- Robotic surgery not available in-country
- Trastuzumab not reliably stocked publicly
- India costs reachable with family support
- Direct visa processing via GAF Healthcare
"I had been told in Lagos that the drug I needed was not available in Nigeria. In India, I started it within ten days of arriving. The price was something my family could actually manage."
The four hospitals GAF Healthcare recommends most
These are the centres we direct the majority of our breast cancer patients to. Each has been assessed for surgical volume, oncology team credentials, reconstruction capability, international patient infrastructure, and — critically — honest outcome reporting.
Apollo Hospitals — Delhi & Chennai
India's largest private oncology network. Over 1,200 oncology surgeries per month across the Apollo group. Full spectrum of breast procedures — lumpectomy, nipple-sparing mastectomy, DIEP flap reconstruction — performed by surgeons trained at MD Anderson and Sloan Kettering. Dedicated international patient centre with multilingual coordinators. Biosimilar trastuzumab available at $300–$500 per cycle.
Fortis Memorial Research Institute — Gurgaon
96% negative surgical margin rates in breast surgery — one of the highest reported in India. Fortis Memorial's breast oncology team runs a dedicated weekly tumour board. Full sentinel node biopsy and intraoperative frozen section capability. Particularly strong for patients combining neoadjuvant chemotherapy with surgical planning. Consistent choice for patients from East Africa and the Gulf.
Medanta — The Medicity, Gurgaon
Home to one of India's most experienced reconstructive surgery teams. Medanta's plastic surgeons have individual DIEP flap case volumes above 500 procedures. The oncology division has an established track record with patients from Nigeria, Kenya, Tanzania, Bangladesh, and Oman. A strong first choice for patients who need mastectomy with immediate flap reconstruction.
Tata Memorial Hospital — Mumbai
India's foremost dedicated cancer centre. Tata Memorial treats more breast cancer patients annually than most European national cancer systems. Its surgical and medical oncology faculty publish in The Lancet Oncology and the Journal of Clinical Oncology. For complex, locally advanced, inflammatory, or rare breast cancer presentations, Tata Memorial is the benchmark institution in Asia.
How the process works — from your country to discharge
The process of arranging breast cancer treatment in India is more straightforward than most patients expect. GAF Healthcare manages every step — so that by the time you arrive in India, your surgical date is confirmed, your hospital room is ready, and your oncology team has already reviewed your case.
Submit your reports — remotely, from home
Send your biopsy report, receptor status, staging scans, and any existing treatment records to GAF Healthcare. No travel required at this stage. Our medical team reviews your case and connects you with an Indian oncologist within 24 hours.
Receive your treatment plan and cost estimate
We coordinate quotes from two to three shortlisted hospitals based on your diagnosis, stage, subtype, and budget. All figures are itemised — surgery, anaesthesia, hospital stay, drugs, and pathology. No hidden costs. You choose the hospital that suits you best.
Apply for your Indian medical visa
GAF Healthcare provides the hospital invitation letter you need for your visa application. India's medical visa covers you and up to two accompanying family members. Most nationalities from Africa and the Gulf receive approval within five to ten working days.
Arrive, complete workup, and begin treatment
Airport transfer is arranged. The pre-surgical workup — blood tests, ECG, imaging review, anaesthesia assessment — is completed within 24 to 48 hours of arrival. Surgery follows one to two days later. Your room, dietary preferences, and any accessibility requirements are arranged in advance.
Recover and return home with complete documentation
Lumpectomy patients are typically fit to fly within ten to fourteen days. Mastectomy patients within three to four weeks. Your discharge pack includes a complete surgical record, pathology report, adjuvant treatment plan, and a written handoff document for your local oncologist — in English, formatted for international use. GAF Healthcare follows up with you and your home doctor at 30 and 90 days post-discharge.
Many patients complete their surgical episode in India and continue chemotherapy or endocrine therapy at home with their local oncologist. GAF Healthcare coordinates the full treatment plan documentation so your local doctor can continue exactly where the Indian team left off. Some patients return to India for monitoring scans and treatment adjustments every three to six months. Both models work — and we help you decide which is right for your situation.
Take the first step. It costs nothing and takes less than 24 hours.
Share your diagnosis with GAF Healthcare. We will review your case, recommend the right hospital and oncologist in India, give you transparent cost figures, and walk you through exactly what happens next — at no charge, no obligation.
Start My Free Consultation →